Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2025-12-24 @ 3:43 PM
NCT ID: NCT05793892
Eligibility Criteria: Inclusion Criteria: * (1) fully informed, fully understand the trial content, process, benefits and possible adverse reactions, and voluntarily participate in the trial, and sign the informed consent; * 2、Aged 18-65 years old (including the boundary value), gender is not limited; * (3) Body mass index (BMI) between 18.5-28.0 kg/m2 (including the boundary value); * (4) plan to perform facial lattice laser cosmetic; * (5) The subject can communicate well with the investigator and can complete the study in accordance with the provisions of the study. Exclusion Criteria: * (1) At screening, the investigator judged that the subject has facial skin damage, peeling, tattoo, scar, atopic dermatitis, urticaria or other skin diseases that may interfere with the study objectives and evaluation; * (2) sensory disturbance, hyperalgesia, migraine, herpes zoster, trigeminal neuralgia and other head and facial pain affect the efficacy evaluation; * (3) Those who have used any analgesics within 24 hours before surgery; * (4) Patients with allergic constitution \[to two or with substances (dust, pollen, food, drugs, etc.)\], or known to be allergic to lidocaine, tetracaine or other amide or ester local anesthetics and its excipients or p-aminobenzoic acid (PABA); * (5) Those who are sensitive to systemic effects of lidocaine and tetracaine (such as acute disease, severe liver disease or pseudocholinesterase deficiency);
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT05793892
Study Brief:
Protocol Section: NCT05793892